A New Drug Candidate (GEMSP) for Multiple Sclerosis

E-ISSN： 1875-533x|16|25|3203-3214

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.25, 2009-09, pp. : 3203-3214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GEMSP: A New Therapeutic Approach to Multiple Sclerosis

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 3, 2012-09 ,pp. : 173-181

Bentham Science Publishers

Access to resources Recommend Favorite

New methods for multiple sclerosis drug discovery

By Warford Jordan Robertson George S

Expert Opinion on Drug Discovery, Vol. 6, Iss. 7, 2011-07 ,pp. : 689-699

Informa Healthcare

Access to resources Recommend Favorite

Genomics and new targets for multiple sclerosis

By Baranzini Sergio E Oksenberg Jorge R

Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. : 151-161

Future Medicine

Access to resources Recommend Favorite

Choosing Drug Therapy for Multiple Sclerosis: An Update

By van Oosten B.W.

Drugs, Vol. 56, Iss. 4, 1998-10 ,pp. : 555-569

Adis International

Access to resources Recommend Favorite

Recent advances in preclinical drug development in multiple sclerosis

By Hoban C.J.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 831-854

Informa Healthcare

Access to resources Recommend Favorite